Lower baseline cerebrospinal fluid amyloid-β 42 is associated with amyloid-related imaging abnormalities during real-world lecanemab treatment.

Leqembi (lecanemab-irmb) - Biogen, Eisai

http://www.ncbi.nlm.nih.gov/pubmed/42742530

Akira Hashiramoto; Eiji Mizuta; Hisatomo Kowa; Jun Fujita; Kohsuke Yoshida; Ryuichi Takahashi; Tetsuo Kashibayashi

Sep 16, 2026